NAD+ and Kidney Health After 40: What the Research Suggests

Most of us think about our heart after 40. We track our cholesterol, pay attention to our blood pressure, and maybe start noticing our joints on the stairs. The kidneys rarely make the list. They sit quietly behind the lower ribs, filtering roughly 180 liters of blood plasma a day, and they almost never complain until something has already changed.

Yet the kidneys are among the most energy-hungry organs in the body, and that makes them a surprisingly interesting place to look when researchers study aging. A growing field of research is exploring the relationship between NAD+ and kidney health, and the early findings suggest that the same molecule tied to cellular energy, DNA repair, and metabolism may also play a meaningful role in how well our kidneys handle the wear and tear of midlife. Here is what the science actually says, what it does not say yet, and what you can do today.

The Quiet Organ That Changes With Age

Kidney function is usually described by a number called the glomerular filtration rate, or GFR. It estimates how much blood your kidneys filter each minute, and it is the figure your doctor looks at when reviewing a standard metabolic panel.

Like muscle mass and bone density, GFR drifts downward with time, even in people who are otherwise healthy. A review in Advances in Chronic Kidney Disease examined carefully screened, healthy kidney donors and found that GFR declines by about 6.3 mL/min/1.73 m² per decade [1]. The same review described the structural changes behind that decline: fewer functioning filtering units, a gradual stiffening of the small blood vessels that feed them, and a modest shrinking of the outer kidney tissue.

The authors made an important point that is often lost in conversation. This slow change is a normal part of aging, not a disease. But they also noted that it matters, because older kidneys have less functional reserve. In practical terms, that means a kidney at 55 has less of a buffer than it did at 30 when it faces stress, whether that stress is dehydration, a severe illness, a surgery, or years of elevated blood pressure.

That idea of reserve is where cellular energy enters the story.

Why Your Kidneys Burn So Much Energy

Filtering blood is only the first step. The real heavy lifting happens afterward, in a long network of tiny tubes that reclaim water, glucose, sodium, and other essentials your body cannot afford to lose. That reabsorption is an active process. It runs on ATP, the energy currency made inside mitochondria.

Kidney tubule cells are packed with mitochondria for exactly this reason. Pound for pound, the kidneys consume a remarkable share of the body's oxygen, second only to the heart in mitochondrial density by some estimates. And mitochondria cannot make ATP efficiently without NAD+, the coenzyme that shuttles electrons through the energy-producing chain.

A review in Nature Reviews Nephrology summarized why this matters so much for renal tissue [2]. NAD+ is not just a fuel helper. It is also the required partner for sirtuins, a family of enzymes linked to mitochondrial maintenance and stress resistance, and for PARPs, the enzymes that help repair damaged DNA. The authors described the kidney as especially sensitive to disruptions in NAD+ balance because its cells depend so heavily on steady mitochondrial output. When NAD+ supply falls, tubule cells appear to lose some of their ability to cope with stress.

What Happens to NAD+ as We Age

NAD+ levels are not fixed across a lifetime. A study in Rejuvenation Research measured the NAD+ metabolome in the plasma of healthy adults across a wide age range and found that NAD+ levels were lower in older participants, while markers associated with NAD+ consumption shifted in the opposite direction [3]. The researchers described this pattern as a dysregulation that occurs even in "normal" aging, without any specific disease present.

Researchers believe several forces contribute to that decline. Chronic low-grade inflammation increases the activity of an enzyme called CD38, which breaks down NAD+. Accumulated DNA damage keeps repair enzymes busy, and those enzymes consume NAD+ as they work. Meanwhile, the recycling pathways that rebuild NAD+ may become less efficient with time.

For an organ that runs on mitochondrial energy, a slowly shrinking NAD+ pool is a reasonable thing for scientists to investigate. It does not mean falling NAD+ causes age-related kidney changes on its own. Kidney aging has many drivers, including blood pressure, blood sugar, genetics, and lifestyle. But it does help explain why kidney researchers have become so interested in this molecule.

NAD+ and Kidney Health: What Human Studies Show

Much of the early work on NAD+ and kidney stress came from laboratory models, but several human studies have now added real-world weight to the conversation.

The most cited comes from a team at Beth Israel Deaconess Medical Center, published in Nature Medicine [4]. The researchers studied acute kidney injury, a sudden drop in kidney function that can occur after major surgery or during critical illness. They found that one of the pathways the body uses to build NAD+ from the amino acid tryptophan becomes impaired during kidney stress, and that a urine marker reflecting this bottleneck predicted which critically ill patients went on to develop kidney injury.

The team then ran a small phase 1, placebo-controlled study in people undergoing cardiac surgery, giving oral nicotinamide, a form of vitamin B3 that the body converts into NAD+. Their summary of the findings was notable:

"NAM was well tolerated and was associated with less AKI. Therefore, impaired NAD+ biosynthesis may be a feature of high-risk hospitalizations for which NAD+ augmentation could be beneficial." Poyan Mehr et al., Nature Medicine, 2018 [4]

It is worth reading that carefully. This was an early safety study in a specific hospital population, not a trial in healthy adults, and "associated with" is not the same as proof. Still, it was one of the first signals in humans that the NAD+ supply of the kidney may be relevant to how it handles stress.

A follow-up study in BMC Nephrology tested a combination of nicotinamide riboside and pterostilbene in 24 hospitalized patients with acute kidney injury [5]. In the placebo group, whole blood NAD+ levels dropped by roughly half over 48 hours. In patients receiving the NAD+ precursor combination, NAD+ levels rose by about 37% across all doses combined. Importantly, kidney safety markers such as creatinine and eGFR did not worsen, and only a few participants reported minor digestive side effects.

In healthier people, the most relevant evidence comes from a randomized, placebo-controlled crossover trial in Nature Communications [6]. Healthy middle-aged and older adults took nicotinamide riboside for six weeks. The supplement was well tolerated and effectively raised NAD+ metabolism. While the study was not designed to measure kidney function directly, the researchers observed trends toward lower systolic blood pressure and reduced arterial stiffness in participants with elevated baseline blood pressure, and they recommended larger trials to explore those effects. Because blood pressure and vascular health are closely linked to long-term kidney health, that finding has drawn interest from nephrologists.

Reading the Evidence Honestly

It would be easy to take these studies and overstate them, so here is a clear-eyed summary.

What studies suggest:

• Kidney cells depend heavily on mitochondrial energy, and NAD+ is central to that energy production [2].
• NAD+ levels tend to decline with age, even in healthy adults [3].
• In hospitalized patients under kidney stress, NAD+ pathways appear disrupted, and early trials of NAD+ precursors raised NAD+ levels without harming kidney safety markers [4, 5].
• In healthy middle-aged and older adults, raising NAD+ appears well tolerated and may support vascular measures that are related to kidney health [6].

What we do not know yet:

• Whether raising NAD+ changes the natural, age-related decline in GFR in healthy people.
• The ideal form, dose, or route of NAD+ support for long-term kidney outcomes.
• How results in hospitalized patients translate to everyday wellness.

That gap is normal for an emerging field. The science is promising enough to take seriously and early enough to approach with patience. Anyone with diagnosed kidney disease should make decisions about NAD+ or any supplement only with their nephrologist.

Everyday Habits That Support Your Kidneys After 40

The strongest tools for long-term kidney health are not glamorous, but they are well established. Many of them also happen to support healthy NAD+ metabolism.

Know your numbers. Ask for your eGFR and a urine albumin test at your annual physical. These two simple results give you a baseline you can track over time, and they catch changes years before symptoms appear.

Keep blood pressure in range. High blood pressure is one of the leading contributors to kidney decline. Regular movement, reducing excess sodium, limiting alcohol, and managing stress all help.

Watch your blood sugar. Elevated glucose over many years strains the small blood vessels in the kidneys. Balanced meals built around protein, fiber, and whole foods may support steadier glucose.

Hydrate thoughtfully. Your kidneys need adequate fluid to do their job. A good rule of thumb is to drink consistently through the day and watch for pale yellow urine, adjusting for heat and exercise.

Be cautious with over-the-counter pain relievers. Frequent use of NSAIDs such as ibuprofen can put stress on the kidneys, especially with dehydration. Talk to your doctor if you rely on them regularly.

Move every day. Exercise is one of the most reliable natural ways to support NAD+ production and mitochondrial health, and it benefits blood pressure and glucose control at the same time.

Protect your sleep. Poor sleep is linked to higher blood pressure and inflammation, both of which matter for the kidneys and for the rate at which NAD+ is consumed.

Where Physician-Supervised NAD+ Fits In

For adults who have the fundamentals in place and want to address the cellular side of aging, NAD+ support is one option many people explore. Oral precursors like nicotinamide riboside must be converted by the body, and absorption can vary from person to person. Injectable NAD+ is another approach, designed to deliver the coenzyme directly.

At RenuviaRX, NAD+ injections are prescribed only after a board-certified physician reviews your health history, which includes your current medications and any known kidney or liver conditions. Treatment is compounded by a licensed pharmacy, and patients report benefits such as steadier energy and clearer thinking. NAD+ therapy is not a treatment for kidney disease and is not a substitute for care from your own doctor. It is best viewed as one part of a broader healthy aging plan that starts with the habits above.

The Bottom Line

Your kidneys do an extraordinary amount of work without asking for attention, and they age gradually along with the rest of you. The research connecting NAD+ and kidney health is still young, but it points to a compelling idea: organs that burn the most cellular energy may be especially sensitive to the natural decline of the molecule that helps produce it.

The practical takeaway is encouraging. Learn your kidney numbers, protect your blood pressure and blood sugar, stay active and hydrated, and consider whether supporting your cellular energy fits your longevity goals. If you are curious whether NAD+ therapy is right for you, a conversation with a physician is a thoughtful place to begin.

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.

---

References

1. Denic A, Glassock RJ, Rule AD. "Structural and functional changes with the aging kidney." Advances in Chronic Kidney Disease, 2016. https://doi.org/10.1053/j.ackd.2015.08.004

2. Ralto KM, Rhee EP, Parikh SM. "NAD+ homeostasis in renal health and disease." Nature Reviews Nephrology, 2020. https://doi.org/10.1038/s41581-019-0216-6

3. Clement J, Wong M, Poljak A, Sachdev P, Braidy N. "The plasma NAD+ metabolome is dysregulated in 'normal' aging." Rejuvenation Research, 2019. https://doi.org/10.1089/rej.2018.2077

4. Poyan Mehr A, Tran MT, Ralto KM, et al. "De novo NAD+ biosynthetic impairment in acute kidney injury in humans." Nature Medicine, 2018. https://doi.org/10.1038/s41591-018-0138-z

5. Simic P, Vela Parada XF, Parikh SM, Dellinger R, Guarente LP, Rhee EP. "Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI." BMC Nephrology, 2020. https://doi.org/10.1186/s12882-020-02006-1

6. Martens CR, Denman BA, Mazzo MR, et al. "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults." Nature Communications, 2018. https://doi.org/10.1038/s41467-018-03421-7